Association of inflammatory markers with the severity of COVID-19: A meta-analysis
- PMID: 32425643
- PMCID: PMC7233226
- DOI: 10.1016/j.ijid.2020.05.055
Association of inflammatory markers with the severity of COVID-19: A meta-analysis
Abstract
Objectives: Studies reported associations of inflammatory markers with the severity of COVID-19, but conclusions were inconsistent. We aimed to provide an overview of the association of inflammatory markers with the severity of COVID-19.
Methods: We searched PubMed, Embase, Cochrane Library, Wanfang and China National Knowledge Infrastructure (CNKI) database until March 20, 2020. Weighted mean difference (WMD) and 95% confidence intervals (CIs) were pooled using random or fixed-effects models.
Results: A total of 16 studies comprising 3962 patients with COVID-19 were included in our analysis. Random-effect results demonstrated that patients with COVID-19 in the nonsevere group had lower levels for CRP (WMD = -41.78 mg/l, 95% CI = [-52.43, -31.13], P < 0.001), PCT (WMD = -0.13 ng/ml, 95% CI = [-0.20, -0.05], P < 0.001), IL-6 (WMD = -21.32 ng/l, 95% CI = [-28.34, -14.31], P < 0.001), ESR (WMD = -8 mm/h, 95% CI = [-14, -2], P = 0.005), SAA (WMD = -43.35 μg/ml, 95% CI = [-80.85, -5.85], P = 0.020) and serum ferritin (WMD = -398.80 mg/l, 95% CI = [-625.89, -171.71], P < 0.001), compared with those in the severe group. Moreover, survivors had a lower level of IL-6 than non-survivors (WMD = -4.80 ng/ml, 95% CI = [-5.87, -3.73], P < 0.001). These results were consistent through sensitivity analysis and publication bias assessment.
Conclusions: The meta-analysis highlights the association of inflammatory markers with the severity of COVID-19. Measurement of inflammatory markers might assist clinicians to monitor and evaluate the severity and prognosis of COVID-19.
Keywords: COVID-19; Inflammatory markers; Meta-analysis; SARS-CoV-2; Severity.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




References
-
- Chang Z., Yang W., Wang Q., Liao G. Clinical significance of serum hs-CRP, IL-16, and PCT in diagnosis and prognosis of patients with COVID-19 (In Chinese) Drugs Clin. 2020;35(3)
-
- Chen C., Chen C., Yan J.T., Zhou N., Zhao J.P., Wang D.W. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19 (In Chinese) Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:E008. - PubMed
-
- Chen L., Liu H.G., Liu W., Liu J., Liu K., Shang J. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia (In Chinese) Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(3):203–208. - PubMed
-
- Cheng K., Wei M., Shen H., Wu C., Chen D., Xiong W. Clinical characteristics of 463 patients with common and severe type coronavirus disease (In Chinese) Shanghai Med J. 2020:1–15.
-
- National Health Commission of China . 2020. The notice of launching guideline on diagnosis and treatment of the novel coronavirus pneumonia. (In Chinese)http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous